IN BRIEF FASB's recent guidance on accounting joint ventures, ASU 2023-5, is intended to resolve diversity in practice and ...
Reports another quarter of strong EPS growth Continued net interest margin expansion Strong expense control ST. LOUIS, April 23, 2026 (GLOBE ...
Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition
The biotech sector is transitioning away from a framework dominated by long-term research spending toward one in which scientific progress can be directly reflected in financial valuation. As drug ...
Boston Scientific Corporation generated net sales of $5.203 billion during the first quarter of 2026, growing 11.6 percent on a reported basis and 9.4 percent on an operational1 and organic2 basis, ...
Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.
Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.203 billion during the first quarter of 2026 ...
Agree Realty Corporation (the "Company") today announced results for the quarter ended March 31, 2026. All per share amounts included herein are on a diluted per common share basis unless otherwise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results